The U.S. Food and Drug Administration approved Risperdal (risperidone) tablets for the symptomatic treatment of irritability in autistic children and adolescents.
The approval of the adult antipsychotic drug is the first use of a drug to treat behaviors associated with autism in children.
The FDA said these behaviors are included under the general heading of irritability, and include aggression, deliberate self-injury, and temper tantrums